{"Title": "Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus", "Year": 2019, "Source": "BJS Open", "Volume": "3", "Issue": 6, "Art.No": null, "PageStart": 767, "PageEnd": 776, "CitedBy": 1, "DOI": "10.1002/bjs5.50211", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85078952890&origin=inward", "Abstract": "\u00a9 2019 The Authors. BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd.Background: A positive circumferential resection margin (CRM) has been associated with higher rates of locoregional recurrence and worse survival in oesophageal cancer. The aim of this study was to establish if clinicopathological and radiological variables might predict CRM positivity in patients who received neoadjuvant chemotherapy before surgery for oesophageal adenocarcinoma. Methods: Multivariable analysis of clinicopathological and CT imaging characteristics considered potentially predictive of CRM was performed at initial staging and following neoadjuvant chemotherapy. Prediction models were constructed. The area under the curve (AUC) with 95% confidence intervals (c.i.) from 1000 bootstrapping was assessed. Results: A total of 223 patients were included in the study. Poor differentiation (odds ratio (OR) 2\u00b784, 95 per cent c.i. 1\u00b739 to 6\u00b701) and advanced clinical tumour status (T3-4) (OR 2\u00b793, 1\u00b703 to 9\u00b748) were independently associated with an increased CRM risk at diagnosis. CT-assessed lack of response (stable or progressive disease) following chemotherapy independently corresponded with an increased risk of CRM positivity (OR 3\u00b738, 1\u00b743 to 8\u00b750). Additional CT evidence of local invasion and higher CT tumour volume (14 cm3) improved the performance of a prediction model, including all the above parameters, with an AUC (c-index) of 0\u00b776 (0\u00b767 to 0\u00b783). Variables associated with significantly higher rates of locoregional recurrence were pN status (P = 0\u00b7020), lymphovascular invasion (P = 0\u00b7007) and poor response to chemotherapy (Mandard score 4-5) (P = 0\u00b7006). CRM positivity was associated with a higher locoregional recurrence rate, but this was not statistically significant (P = 0\u00b7092). Conclusion: The presence of advanced cT status, poor tumour differentiation, and CT-assessed lack of response to chemotherapy, higher tumour volume and local invasion can be used to identify patients at risk of a positive CRM following neoadjuvant chemotherapy.Antecedentes: Un margen de resecci\u00f3n circunferencial (circumferential resection margin, CRM) positivo se ha asociado con tasas m\u00e1s elevadas de recidiva locorregional y peor supervivencia en el c\u00e1ncer de es\u00f3fago. El objetivo de este estudio fue establecer si las variables cl\u00ednico\u2010patol\u00f3gicas y radiol\u00f3gicas podr\u00edan predecir la positividad del CRM en el adenocarcinoma de es\u00f3fago tras quimioterapia neoadyuvante antes de la cirug\u00eda. M\u00e9todos: Se realiz\u00f3 un an\u00e1lisis multivariable de las caracter\u00edsticas cl\u00ednico\u2010patol\u00f3gicas y de la tomograf\u00eda computarizada (computed tomography, CT) que se consideraron potencialmente predictivas de CRM en la estadificaci\u00f3n inicial y tras la quimioterapia neoadyuvante. Se construyeron modelos de predicci\u00f3n. Se evalu\u00f3 el \u00e1rea bajo la curva (area under curve, AUC) con el i.c. del 95% a partir de 1.000 muestras bootstrap. Resultados: Se incluyeron 223 pacientes en el estudio. Una pobre diferenciaci\u00f3n (raz\u00f3n de oportunidades, odds ratio, OR 2,84, i.c. del 95% 1,39\u20106,01) y un estadio cl\u00ednico T avanzado (T3\u20104) (OR 2,93, i.c. del 95% 1,03\u20109,48) se asociaron de forma independiente con un riesgo aumentado de CRM en el diagn\u00f3stico. La falta de respuesta en la CT (estable o enfermedad en progresi\u00f3n) tras la quimioterapia se correspond\u00eda de forma independiente con un riesgo aumentado de CRM positivo (OR 3,38, i.c. del 95% 1,43\u20108,50). Adem\u00e1s, la evidencia por CT de invasi\u00f3n local y un mayor volumen del tumor en CT (14 cm3) mejoraron el funcionamiento del modelo predictivo, incluyendo todos los par\u00e1metros previamente se\u00f1alados; con AUC (\u00edndice c) de 0,76 (0,68\u20100,83). Las variables asociadas de forma significativa con tasas m\u00e1s elevadas de recidiva locorregional fueron el estado de los ganglios linf\u00e1ticos patol\u00f3gicos (P = 0,002), la invasi\u00f3n linfovascular (P = 0,007) y la respuesta pobre a la quimioterapia (Mandard 4 y 5 (P = 0,006)). La positividad del CRM se asoci\u00f3 con una tasa de recidiva locorregional m\u00e1s elevada pero sin alcanzar significaci\u00f3n estad\u00edstica (P = 0,09). Conclusi\u00f3n: La presencia de un estadio cl\u00ednico T avanzado, tumor pobremente diferenciado, falta de respuesta a la quimioterapia en la TC, mayor volumen del tumor en la TC e invasi\u00f3n local pueden ser utilizados para identificar pacientes en riesgo de un CRM positivo tras quimioterapia neoadyuvante.", "AuthorKeywords": null, "IndexKeywords": ["Adenocarcinoma", "Chemotherapy, Adjuvant", "Esophageal Neoplasms", "Esophagectomy", "Esophagus", "Feasibility Studies", "Female", "Humans", "Male", "Margins of Excision", "Middle Aged", "Neoadjuvant Therapy", "Neoplasm Recurrence, Local", "Neoplasm Staging", "Predictive Value of Tests", "Preoperative Period", "Prognosis", "Retrospective Studies", "Risk Assessment", "ROC Curve", "Tomography, X-Ray Computed", "Tumor Burden"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85078952890", "SubjectAreas": null, "AuthorData": {"57210718812": {"Name": "Knight W.R.C.", "AuthorID": "57210718812", "AffiliationID": "60011520", "AffiliationName": "School of Cancer and Pharmaceutical Sciences, King's College London"}, "56215139000": {"Name": "Zylstra J.", "AuthorID": "56215139000", "AffiliationID": "60011520", "AffiliationName": "Department of Surgery, Guy's and St Thomas' Oesophago-Gastric Centre, King's College London"}, "55232331100": {"Name": "Baker C.R.", "AuthorID": "55232331100", "AffiliationID": "60011520", "AffiliationName": "Department of Surgery, Guy's and St Thomas' Oesophago-Gastric Centre, King's College London"}, "57192125766": {"Name": "Kelly M.", "AuthorID": "57192125766", "AffiliationID": "60011520", "AffiliationName": "Department of Surgery, Guy's and St Thomas' Oesophago-Gastric Centre, King's College London"}, "10144295400": {"Name": "Gossage J.A.", "AuthorID": "10144295400", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "7005124006": {"Name": "Lagergren J.", "AuthorID": "7005124006", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "56901921900": {"Name": "Davies A.R.", "AuthorID": "56901921900", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "57204145391": {"Name": "Ngan S.", "AuthorID": "57204145391", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "57213817463": {"Name": "Qureshi A.", "AuthorID": "57213817463", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "8605349100": {"Name": "Deere H.", "AuthorID": "8605349100", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "57198531569": {"Name": "Green M.", "AuthorID": "57198531569", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "7403649151": {"Name": "Chang F.", "AuthorID": "7403649151", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "23970990000": {"Name": "Mahadeva U.", "AuthorID": "23970990000", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "55317005900": {"Name": "Gill-Barman B.", "AuthorID": "55317005900", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "56302713000": {"Name": "George S.", "AuthorID": "56302713000", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "24066443800": {"Name": "Dunn J.", "AuthorID": "24066443800", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "26538385700": {"Name": "Zeki S.", "AuthorID": "26538385700", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "7004258334": {"Name": "Meenan J.", "AuthorID": "7004258334", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "55455287500": {"Name": "Hynes O.", "AuthorID": "55455287500", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "57204138483": {"Name": "Tham G.", "AuthorID": "57204138483", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "57204141574": {"Name": "Iezzi C.", "AuthorID": "57204141574", "AffiliationID": "60012311", "AffiliationName": "Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet"}, "57215295961": {"Name": "Yip C.", "AuthorID": "57215295961", "AffiliationID": "60011520", "AffiliationName": "School of Biomedical Engineering and Imaging Sciences, King's College London"}, "7004035095": {"Name": "Goh V.", "AuthorID": "7004035095", "AffiliationID": "60011520", "AffiliationName": "Cancer Epidemiology and Population Health Associated Research Group, King's College London"}, "55372637900": {"Name": "Wulaningsih W.", "AuthorID": "55372637900", "AffiliationID": "60011520", "AffiliationName": "Cancer Epidemiology and Population Health Associated Research Group, King's College London"}, "25932351400": {"Name": "Van Hemelrijck M.", "AuthorID": "25932351400", "AffiliationID": "60011520", "AffiliationName": "Cancer Epidemiology and Population Health Associated Research Group, King's College London"}, "22634157900": {"Name": "Jacques A.", "AuthorID": "22634157900", "AffiliationID": "60005518", "AffiliationName": "Department of Radiology"}, "36106749800": {"Name": "Griffin N.", "AuthorID": "36106749800", "AffiliationID": "60005518", "AffiliationName": "Department of Radiology"}, "6603527999": {"Name": "Maisey N.", "AuthorID": "6603527999", "AffiliationID": "60005518", "AffiliationName": "Department of Oncology"}, "24449923300": {"Name": "Gaya A.", "AuthorID": "24449923300", "AffiliationID": "60005518", "AffiliationName": "Department of Oncology"}, "23479629300": {"Name": "Landau D.", "AuthorID": "23479629300", "AffiliationID": "60005518", "AffiliationName": "Department of Oncology"}, "null": {"Name": null, "AuthorID": null, "AffiliationID": null, "AffiliationName": null}}}